Allergic Contact Dermatitis (Nursing)


Learning Outcome

  1. List the causes of allergic contact dermatitis
  2. Describe the presentation of allergic contact dermatitis
  3. Summarize the treatment of allergic contact dermatitis
  4. Recall the nursing management of allergic contact dermatitis

Introduction

Allergic contact dermatitis (ACD) is a type 4 or delayed-type, hypersensitivity response (DTH) by an individual’s immune system to a small molecule (< 500 daltons), or hapten, that contacts a sensitized individual’s skin.[1] The initial or induction phase of ACD occurs when the hapten combines with a protein to form a complex that leads to the expansion of an allergen-specific T cell population; this process is known as sensitization. During the elicitation phase, re-exposure to the antigen leads to the development of dermatitis.[2] ACD accounts for 20% of contact dermatoses, and allergens differ greatly based upon geography, personal habits and hobbies, and often, the types of preservatives that are legally permissible, such as quaternium-15 in the United States but not Europe.[3]

Nursing Diagnosis

  • Itching
  • Dry skin
  • Anxiety
  • Excoriations

Causes

Allergic contact dermatitis (ACD) is an inflammatory disease of the skin that is caused by a type 4 hypersensitivity reaction. It results from contact of an offending chemical or antigen with the skin.[4] Morphology and location of the dermatitis are often the best indicators of the offending agent. For instance, when found around the wrist it may indicate an allergic response to a bracelet or watchband.

Risk Factors

Allergic contact dermatitis (ACD) is an inflammatory disease of the skin that is common in the general population.  It is the most common type of occupational skin disease.[5]

Assessment

Allergic contact dermatitis (ACD) can present on physical exam as acute or chronic. Acute ACD is typically characterized by an erythematous, eczematous, or vesicular dermatitis. Although ACD may present with a localized, well-demarcated skin eruption, it can also be more widespread. For example, rinse-off products such as shampoo or body wash may come into contact with many parts of the body, leading to a more diffuse presentation. [6] Additionally, in cases where an allergen is consumed systemically, a more diffuse cutaneous reaction may occur. Chronic ACD more commonly presents with lichenification, fissuring, and scale. [7]

Evaluation

A good clinical evaluation of allergic contact dermatitis (ACD) involves a detailed history and physical. The morphology and location of the dermatitis is often the best indicator of the offending agent. Patch testing can be performed to help confirm the diagnosis. If the diagnosis is still not certain, a skin biopsy usually demonstrates spongiosis.[8]

Medical Management

The most definitive treatment of allergic contact dermatitis (ACD) is the identification and removal of the offending agent. Acute allergic contact dermatitis can also be treated with topical or oral corticosteroids.  Oral antihistamines may help with pruritus in some cases.  If ACD involves a delicate area such as skin folds or eyelids, topical calcineurin inhibitors or PDE4 inhibitors may also be effective.  If the allergen is identified, strict avoidance is necessary to prevent recurrence.[4]

In cases of chronic or recalcitrant ACD, patch testing is the gold standard in identifying the causative agent.[9] Successful patch testing requires several components: choice of appropriate chemicals for testing, a positive patch test to relevant allergens, and patient counseling of patch test results. In addition, the American Contact Dermatitis Society’s Contact Allergen Management Program (CAMP) can be utilized to generate a “safe list” of products that do not contain the patient’s allergens.  In the case where allergens cannot be avoided, systemic therapy may be necessary.[2]

Nursing Management

  • Cool compress
  • Use moisturizers
  • Avoid allergens like latex gloves
  • Always get a detailed history of allergens and avoid them

When To Seek Help

  • If rash is severe
  • Fever
  • Eyes and mucous membranes involved
  • Skin breakdown

Outcome Identification

  • No itching
  • Skin well hydrated
  • No blisters or vesicles

Monitoring

  • Intensity of itching
  • Skin dryness
  • Blisters
  • Excoriations
  • Skin breakdown

Coordination of Care

Enhancing pt outcomes is a physicians number one priority. It is important that patients with alletgic contact dermatitis are given strict return precations and are advised on the natuarla progression of the diseae. Patients should not simple be treated and sent out the door with a prescription. It is important to tailor the treatemt to the patient and to the body aprt affected. Patients also need to have follow up with a specialist and continued education. It is important to utilize nurses and ancilary staff to help commincate in a way that the patient undersatnds. Patents should also have contined monitoring and follow up with their primary care physicna who can help coordinate care.

Health Teaching and Health Promotion

Educating patients on allergic contact dermatitis (ACD) involves assisting the patient in identifying their allergic triggers. Patients must then be provided with practical behavioral modifications to help decrease the inflammatory response of this disease. For instance, in professions that require regular use of rubber gloves, it is important that patients can identify the natural rubber allergy and choose a glove type that uses a rubber accelerator (i.e., thiurams, carbamates, mercapto compounds) towards which they do not form a reaction.[10]

Risk Management

Refer patient to eye doctor if eyelids involved

Discharge Planning

  • Avoid allergens
  • Use moisturizers liberally
  • Apply cool compresses
  • Avoid use of fragrances and jewlery made of nickel
  • Eat healthy
  • Wear latex free gloves

Pearls and Other issues

Cross-sensitization may occur in the population affected by allergic contact dermatitis (ACD). This process occurs when an antigen that is chemically similar to an antigen that had previously been sensitized by the host triggers a contact dermatitis. Additionally, systemically-induced allergic dermatitis may take place when an individual who previously has been sensitized to a contact allergin consumes the allergen by another route (inhalation, ingestion, injection).[1]



(Click Image to Enlarge)
<p>Contact Allergy From Band-Aid</p>

Contact Allergy From Band-Aid

DermNet New Zealand


(Click Image to Enlarge)
<p>Contact Allergy From Nickel</p>

Contact Allergy From Nickel

DermNet New Zealand


(Click Image to Enlarge)
<p>Contact Allergy From Rubber</p>

Contact Allergy From Rubber

DermNet New Zealand


(Click Image to Enlarge)
<p>Classic presentation of nickel contact dermatitis involving lower abdomen and id reaction on elbows</p>

Classic presentation of nickel contact dermatitis involving lower abdomen and id reaction on elbows

Contributed by Matilda Nicholas, MD, PhD


(Click Image to Enlarge)
Contact dermatitis on arms after 72 hours of contact with poison ivy.
Contact dermatitis on arms after 72 hours of contact with poison ivy. Contributed by Wikimedia Commons, Larsonja (Public Domain)
Details

Nurse Editor

Jeannie Collins

Editor:

Matthew Mueller

Updated:

7/13/2023 10:15:09 AM

References

[1]

Divkovic M,Pease CK,Gerberick GF,Basketter DA, Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization. Contact dermatitis. 2005 Oct     [PubMed PMID: 16191014]

[2]

Lazzarini R,Mendonça RF,Hafner MFS, Allergic contact dermatitis to shoes: contribution of a specific series to the diagnosis. Anais brasileiros de dermatologia. 2018 Sep-Oct     [PubMed PMID: 30156619]

[3]

Aquino M,Rosner G, Systemic Contact Dermatitis. Clinical reviews in allergy & immunology. 2019 Feb     [PubMed PMID: 29766368]

[4]

Lampel HP,Powell HB, Occupational and Hand Dermatitis: a Practical Approach. Clinical reviews in allergy & immunology. 2019 Feb     [PubMed PMID: 30171459]

[5]

Vocanson M,Hennino A,Rozières A,Poyet G,Nicolas JF, Effector and regulatory mechanisms in allergic contact dermatitis. Allergy. 2009 Dec     [PubMed PMID: 19839974]

[6]

Bock S,Said A,Müller G,Schäfer-Korting M,Zoschke C,Weindl G, Characterization of reconstructed human skin containing Langerhans cells to monitor molecular events in skin sensitization. Toxicology in vitro : an international journal published in association with BIBRA. 2018 Feb     [PubMed PMID: 28941582]

[7]

Esser PR,Martin SF, Pathomechanisms of Contact Sensitization. Current allergy and asthma reports. 2017 Nov 11     [PubMed PMID: 29129023]

[8]

Signore RJ, Prevention of poison ivy dermatitis with oral homeopathic Rhus toxicodendron. Dermatology online journal. 2017 Jan 15     [PubMed PMID: 28329482]

[9]

Snyder M,Turrentine JE,Cruz PD Jr, Photocontact Dermatitis and Its Clinical Mimics: an Overview for the Allergist. Clinical reviews in allergy & immunology. 2019 Feb     [PubMed PMID: 29951786]

[10]

Coenraads PJ,Aberer W,Cristaudo A,Diepgen T,Holden C,Koch L,Schuttelaar ML,Weisshaar E,Fuchs A,Schlotmann K,Goebel C,Blömeke B,Krasteva M, The Allergy Alert Test: Introduction of a Protocol Suitable to Provide an Alert Signal in p-Phenylenediamine-Allergic Hair Dye Users. Dermatitis : contact, atopic, occupational, drug. 2018 Aug 9     [PubMed PMID: 30096055]

[11]

Nicholson P,Brinsley J,Farooque S,Wakelin S, Patch testing with meropenem following a severe cutaneous adverse drug reaction. Contact dermatitis. 2018 Dec     [PubMed PMID: 30156311]

[12]

Nguyen HL,Yiannias JA, Contact Dermatitis to Medications and Skin Products. Clinical reviews in allergy     [PubMed PMID: 30145645]

[13]

Simonsen AB,Foss-Skiftesvik MH,Thyssen JP,Deleuran M,Mortz CG,Zachariae C,Skov L,Osterballe M,Funding A,Avnstorp C,Andersen BL,Vissing S,Danielsen A,Dufour N,Nielsen NH,Thormann H,Sommerlund M,Johansen JD, Contact allergy in Danish children: Current trends. Contact dermatitis. 2018 Nov     [PubMed PMID: 30094861]

[14]

Jaulent C,Dereure O,Raison-Peyron N, Contact dermatitis caused by polyacrylamide/C13-4 isoparaffin/laureth-7 mix in an emollient cream for atopic skin. Contact dermatitis. 2019 Jul     [PubMed PMID: 30684286]

[15]

Li L,Wang Y,Wang X,Tao Y,Bao K,Hua Y,Jiang G,Hong M, Formononetin attenuated allergic diseases through inhibition of epithelial-derived cytokines by regulating E-cadherin. Clinical immunology (Orlando, Fla.). 2018 Oct     [PubMed PMID: 30077805]

[16]

Choi FD,Juhasz ML,Atanaskova Mesinkovska N, Topical Ketoconazole: A Systematic Review of Current Dermatological Applications and Future Developments. The Journal of dermatological treatment. 2019 Jan 22;     [PubMed PMID: 30668185]

[17]

Luckett-Chastain LR,Gipson JR,Gillaspy AF,Gallucci RM, Transcriptional profiling of irritant contact dermatitis (ICD) in a mouse model identifies specific patterns of gene expression and immune-regulation. Toxicology. 2018 Dec 1     [PubMed PMID: 30171875]